Skip to main content

Table 1 Clinical characteristics of 145 patients

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Characteristics No. of Pt (%)
Median age (range) 45 (range 25–69)
   Age < 50 102 (70.3)
   Age ≥ 50 43 (29.7)
Performance status  
   ECOG 0–1 139 (95.9)
   ECOG 2 6 (4.1)
Pathologic characteristics  
   Invasive ductal carcinoma 137 (94.5)
   Others 8 (5.5)
Initial clinical stage  
   IIA 2 (1.4)
   IIB 21 (14.5)
   IIIA 70 (48.3)
   IIIB 34 (23.4)
   IIIC 18 (12.4)
Median tumor size 5.0 cm (range 1.2–12.0 cm)
Inflammatory breast cancer  
   Yes 18 (12.4)
   No 127 (87.6)
Type of surgery  
   Breast conserving 52 (35.9)
   Mastectomy 93 (64.1)
Adjuvant hormonal therapy  
   Yes 63 (43.4)
   No 82 (56.6)
Radiation therapy  
   Yes 128 (88.3)
   No 17 (11.7)
  1. ECOG, Eastern Cooperative Oncology Group.